ARTICLE INFO

Article Type

Case Report

Authors

Saremi   A.T. (1)
Mortazavi   S.M. (*)






(*) ‎“Sarem Fertility & Infertility Research Center (SAFIR)” and “Sarem Cell Research Center (SCRC)” ‎, Sarem Women’s Hospital, Tehran, Iran
(1) ‎“Sarem Fertility & Infertility Research Center (SAFIR)” and “Sarem Cell Research Center (SCRC)” ‎, Sarem Women’s Hospital, Tehran, Iran

Correspondence

Address: Sarem Women’s Hospital, Basij Square, Phase 3, Ekbatan Town, Tehran, Iran. Postal Code: 1396956111‎
Phone: ‎+98 (21) 44670888‎
Fax: ‎+98 (21) 44670432‎
mazy_mor@yahoo.com

Article History

Received:   April  15, 2017
Accepted:   October 20, 2017
ePublished:   November 15, 2017

ABSTRACT

Information & Methods Hydrothorax is a rare disorder in fetal period with the prevalence of 1 in 15,000 ‎pregnancies referring to level 3 clinics, often caused by the accumulation of ‎lymphatic fluid in pleura. Moderate to severe cases are associated with the high ‎incidence of mortality and morbidity in fetal and neonatal period; in this cases, ‎fluid depletion via thoracentesis can reduce the complications of the disease.‎ After doing ultrasonography and screening, a 29-year-old pregnant woman at 31 ‎weeks pregnant was referred to Sarem Hospital due to fetal hydrothorax. In ‎ultrasonography result, the severe right-sided pleural effusion and mediastinal ‎and heart shift to the left were reported. For the fetus, thoracentesis was ‎performed by mother's skin ultrasound. The fluid was reaccumulated after several ‎days. Then, amniotic sac was ruptured and with premature labor pain, caesarian ‎section was done; a neonate was borne with hydrops. At birth, thoracentesis was ‎performed in the neonate and the chest tube was inserted. After 10 days, the ‎neonate was discharged with good condition. The fluid obtained from pleural ‎aspiration was Chylous.‎
Conclusion Hydrothorax is a life-threatening disease in fetal period, whose subsequent ‎complications can be prevented by the timely treatment. Thoracentesis is a ‎standard treatment that can be associated with complications, such as preterm ‎labor and hydrothorax relapse.‎


CITATION LINKS

[1]Castagno R, Carreras E, Toran N, Higueras T, Sánchez MA, Cabero L. Fetal Pleural Effusion. Ultrasound Obstet Gynocol. 2007;30(4): 461-2.
[2]Suárez-Cabezas S, Natera-de Benito D, Pérez-Segura P, Llorente-Otones L, Villar MJA, Rivero-martin MJ. Neonatal Chylothorax and Dysmorphic Phenotype: A Noonan Syndrome?. J Rare Disord Diagn Therapy. 2016;2(2)34-6.
[3]Gathwala G, Singh J, Rattan K, Bhalla K. Nonchylous idiopathic pleural effusion in the newborn. Indian J Crit Care Med. 2011;15(1):46-8.
[4]Longaker MT, Laberge JM, Dansereau J, Langer JC, Crombleholme TM, Callen PW, et al. Primary fetal hydrothorax: Natural history and management. J Pediatr Surg. 1989;24(6):573-6.
[5]Fanaroff AA, Martin RJ. Neonatal-perinatal medicine: Diseases of the fetus and infant. Maryland: Mosby; 1987.
[6]Taylor PM. Neonatal-perinatal medicine: Diseases of the fetus and infant. J Am Med Assoc. 1988;260(17):2580.
[7]Singh P, Ahmed F. Congenital pulmonary lymphangiectasis resulting in pleural effusions managed by thoracoamniotic shunting. J Ped Surg Case Rep. 2013;1(6):147-51.
[8]Aguirre O, Finley B, Ridgway L, Bennett T, Cowles T. Resolution of unilateral fetal hydrothorax with associated non‐immune hydrops after intrauterine thoracentesis. Ultrasound Obstet Gynecol. 1995;5(5):346-8.
[9]Hidaka N, Chiba Y. Fetal hydrothorax resolving completely after a single thoracentesis: A report of 2 cases. J Reprod Med. 2007;52(9):843-8.
[10]Nicolaides KH, Azar GB. Thoraco-amniotic shunting. Fetal Diagn Ther. 1990;5(3-4):153-64.
[11]Shih YT, Su PH, Chen JY, Lee IC, Hu JM, Chang HP. Common etiologies of neonatal pleural effusion. Pediatr Neonatol. 2011;52(5):251-5.
[12]Hagay Z, Reece EA, Roberts A, Hobbins JC. Isolated fetal pleural effusion: A prenatal management dilemma. Obstet Gynecol. 1993;81(1):147-52.